logo-en
  • Home
  • Companies
  • Investors
    • Home
  • FinTech Hub
  • News
LoginRegister
  • english iconEnglish
  • english iconArabic
  1. Mubasher News
  2. Hanmi pacts with Tabuk Pharmaceuticals to expand into MENA

Hanmi pacts with Tabuk Pharmaceuticals to expand into MENA

NOHA.GAD
Oct 10, 2024
South Korea's Hanmi partnered with Tabuk Pharmaceuticals to export its innovative drugs to MENA

Riyadh - Sharikat Mubasher: South Korea’s Hanmi Pharmaceutical entered into an exclusive licensing agreement with the Saudi leading pharmaceuticals company Tabuk Pharmaceuticals to export its flagship products to the Middle East and North Africa (MENA) region.

In a statement, Hanmi revealed that it will export its innovative new drugs that have already received validation in key markets such as the United States and South Korea.

Through this partnership, the South Korean company aims to gradually expand its product offerings and strengthen its presence in the region over time.

The signing ceremony was attended by Ismail Shehada, CEO of Tabuk Pharmaceutical, Wisam Al Khatib, CBO of Tabuk Pharmaceutical, Ju Hyun Lim, Vice Chairman of Hanmi Pharmaceutical, and representatives from Hanmi Pharmaceuticals Global Headquarters.

The partnership will enable Tabuk Pharmaceutical to obtain local approvals and commence the full-scale commercialization of several innovative and specialized pharmaceutical products developed by Hanmi.

Both companies aspire to introduce cutting-edge treatments across the region and improve healthcare outcomes, leveraging their cutting-edge research and Development capabilities.

CEO Shehada stated that the partnership will enable the company to introduce innovative therapies to the MENA region.

“Our combined expertise will ensure these breakthrough treatments reach healthcare providers and patients, bringing meaningful value to the healthcare system,” Shehada added.

On his part, Hanmi’s Vice Chairman, commented: " This partnership reflects our mutual dedication to addressing significant healthcare challenges and improving patient outcomes. We can create synergy by combining Hanmi's research expertise with Tabuk's strong regional presence. We will do our best to bring meaningful changes to patients' lives in the MENA region."

It is worth mentioning that the initial rollout will focus on urology treatments and anticancer biopharmaceuticals, marking the first wave of products to enter the market. 

Tags

Saudi Arabia
Pharmaceuticals
MENA
exports
Share

Attract clients with your ad

Start Now

Trending

Klivvr upgrades AI financial assistant with In-Chat money transfers
MUBASHER
du unveils National HyperAI to scale AI adoption across UAE
MUBASHER
Monsha’at signed several agreements to strengthen Saudi entrepreneurship ecosystem
MUBASHER.SA
Sabika raises funding to scale precious metals investment platform
MUBASHER
UAE-based fintech firm Mal opens new office in Egypt
MUBASHER

Related News

Private Equities News
Calendar Icon
Nov 16, 2026
du unveils National HyperAI to scale AI adoption across UAE
Read More
Private Equities News
Calendar Icon
Nov 16, 2026
Monsha’at signed several agreements to strengthen Saudi entrepreneurship ecosystem
Read More
Private Equities News
Calendar Icon
Nov 15, 2026
UAE-based fintech firm Mal opens new office in Egypt
Read More
Private Equities News
Calendar Icon
Nov 15, 2026
Alwaleed Philanthropies, RDIA sign strategic R&D partnership
Read More
Private Equities News
Calendar Icon
Nov 15, 2026
HUMAIN partners with VUZ to advance AI Learning through HUMAIN+
Read More
Private Equities News
Calendar Icon
Nov 15, 2026
THC signs $568mn Bombardier deal to launch business aviation fleet
Read More
Private Equities News
Calendar Icon
Nov 12, 2026
FII Institute reschedules 10th Future Investment Initiative to October 2027
Read More

Sharikat Mubasher Newsletter

Get insights and exclusive content from the world of business and finance that you can trust delivered to your inbox

Email is Required
Should be a valid email

Democratizing private equity investments

  • Home
  • Companies
  • Investors
  • FinTech Hub
  • News
  • Contact Us
  • Sitemap
2024 All rights reserved to Sharikat Mubasher